By David Wild
Barcelona, Spain—Microvilli may be small, but they tell many tales.
Two studies presented at the 2019 United European Gastroenterology Week found that the height of ileal epithelial microvilli can predict the likelihood that a patient with Crohn’s disease will respond to biologic therapy. Experts said the findings could lead to improvements in how clinicians manage patients with inflammatory bowel disease by optimizing drug treatment.
In one study (late-breaking abstract